Effect of Vitamin D Supplement on Osteoprotegin Expression and Disease Progression in Patients With Chronic Kidney Disease Stage 1 and 2
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.
Also called NCT01561222
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 300 participants
- Sponsor
- Taixing People's Hospital
- Registry
-
NCT01561222
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- Not reported
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT01561222. Randomized; double masking; primary purpose prevention. Start 2015-07 (registry gives no type); primary completion 2016-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Vitamin D Supplement on Osteoprotegin Expression and Disease Progression in Patients With Chronic Kidney Disease Stage 1 and 2
- Condition
- Chronic Kidney Disease Stage 1
- Condition
- Chronic Kidney Disease Stage 2
- Intervention (Drug)
- Calcitriol
- Intervention (Drug)
- placebo
- Lead sponsor
- Taixing People's Hospital
Record details
- Record id
cardio:ct-nct01561222- Content hash
b75e56ff586f4da7f51f0b1077cfbb8fa38e90da846524e7223a1a6384a8c6f5